LRRTM1 and ovarian carcinoma: For RFS of patients with ovarian cancer, SPOCK2 and FAXDC2 were unfavorable prognostic biomarkers but ADAMDEC1, CCNA2, FAM181A, FOXA2, LRRTM1, NEIL3 and XPR1 were favorable prognostic biomarkers (Figure 4B).